1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6182B5C098B186FE985257E1B004C6374
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-medical-device-quality-2014-15-ma-impact-improvement-approaches?opendocument
18
19opendocument
203.227.254.12
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Quality, Compliance and Regulatory Integration

Benchmarking Medical Device Quality 2014-15: M&A Impact and Improvement Approaches

ID: 5357


Features:

4 Info Graphics

25 Data Graphics

250+ Metrics


Pages/Slides: 40


Published: 2015


Delivery Format: Online , PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Benchmarking Medical Device Quality 2014-15: M&A Impact and Improvement Approaches"

STUDY OVERVIEW

Medical device and diagnostics companies spend millions to ensure their products meet quality standards at every stage of the product lifecycle. While they continually strive to ensure quality and safety in their company's products, quality leaders must also keep an eye on costs at the same time. Balancing these goals is a challenging task in today's environment of frequent mergers/acquisitions and regulatory change.

To help quality leaders better deal with issues around M&A and effectiveness, Best Practices, LLC undertook this study to explore the impact of M&A and integration efforts on the quality function as well as what types of programs quality leaders are using to improve their effectiveness. Research findings provide evidence-based benchmarks around these issues so quality leaders can compare their efforts with industry peers.

This study contains a Large Company Segment (LCS) that is made up of 11 companies.


KEY TOPICS

  • Acquisitions & Quality Function Integration
  • Quality Metrics, Improvement Approaches & Controls
  • Top Challenge Areas for Quality Organizations


KEY METRICS
  • Total acquisitions made since 2012
  • Number of acquisitions since 2012 that had immediate realizable revenue
  • Percentage of acquired facilities where quality staff and systems have been fully integrated
  • Models that best describe current and future state of your quality system
  • Effectiveness of approaches by which quality supports rapid M&A integration
  • Number of SOPs for quality organization at three levels
  • Effectiveness of approaches to develop quality systems that respond rapidly to problems
  • Effectiveness of approaches to tie quality controls to quality attributes of products
  • Which KPIs are used in dashboard to assess quality performance
  • Effectiveness of these metrics for determining the risk your distribution poses to quality function
  • Current statistical confidence level for the product classes listed
  • Top three challenges your quality function will face in next 1-2 years
SAMPLE KEY FINDINGS
  • Approaches that Improve Flexibility: Approaches most often rate “Highly Effective” are simplification, early warning systems and performance dashboards. More than half of benchmark class and large companies consider failure mode effect analysis highly effective for quality control. 56 percent of large companies and 47% of benchmark companies also find product drawings very effective for QC.

METHODOLOGY
  • Best Practices, LLC designed and deployed a custom benchmarking survey to executives at 21 leading Medical Device companies. This study has two segments: Total Benchmark Class (TBC) made up of 21 companies and a Large Company Segment (LCS) that is made up of 11 companies.


Industries Profiled:
Medical Device; Pharmaceutical; Health Care


Companies Profiled:
3M Pharmaceuticals; DePuy Synthes; Baxter Healthcare; Atri Cure; Beckman Coulter; BMC Medical; Becton Dickinson; Bio Tek; Boston Scientific; Cook Medical; Covidien; Endologix; Edwards Lifesciences; Helmer Scientific; Ethicon; GE Healthcare; Medtronic; BARD; Haemonetics Corporation; Invacare Corporation; Lake Region Medical

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.